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Abstract
In 2011, a novel Orthobunyavirus was identified in cattle and sheep in Germany and the Netherlands. This virus was named
Schmallenberg virus (SBV). Later, presence of the virus was confirmed using real time RT-PCR in cases of congenital
malformations of bovines and ovines in several European countries, including Belgium. In the absence of specific
sequencing protocols for this novel virus we confirmed its presence in RT-qPCR positive field samples using DNase SISPA-
next generation sequencing (NGS), a virus discovery method based on random amplification and next generation
sequencing. An in vitro transcribed RNA was used to construct a standard curve allowing the quantification of viral RNA in
the field samples. Two field samples of aborted lambs containing 7.66 and 7.64 log10 RNA copies per mL total RNA allowed
unambiguous identification of SBV. One sample yielded 192 SBV reads covering about 81% of the L segment, 56% of the M
segment and 13% of the S segment. The other sample resulted in 8 reads distributed over the L and M segments. Three
weak positive field samples (one from an aborted calf, two from aborted lambs) containing virus quantities equivalent to
4.27–4.89 log10 RNA copies per mL did not allow identification using DNase SISPA-NGS. This partial sequence information
was compared to the whole genome sequence of SBV isolated from bovines in Germany, identifying several sequence
differences. The applied viral discovery method allowed the confirmation of SBV in RT-qPCR positive brain samples.
However, the failure to confirm SBV in weak PCR-positive samples illustrates the importance of the selection of properly
targeted and fresh field samples in any virus discovery method. The partial sequences derived from the field samples
showed several differences compared to the sequences from bovines in Germany, indicating sequence divergence within
the epidemic.
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Introduction
During the summer and autumn of 2011, a novel disease with
symptoms including fever, decreased milk production and
diarrhea, was identified in dairy cattle in Germany and The
Netherlands [1,2]. Using a metagenomic analysis on next
generation sequence data produced from the blood of symptom-
atic animals, a novel Orthobunyavirus was shown to be associated
with the disease [1]. The virus was preliminary named Schmallen-
berg virus (SBV) according to the geographical location of the
index case. A specific real time RT-PCR test was developed,
confirming the presence of the virus in diseased bovines. Animal
experiments with the isolated virus further supported a causal
relationship between the virus and the disease [1]. In addition, the
virus proved to be associated with an outbreak of congenital
malformations and abortions in both ovine and bovine [1,3,4].
The dissemination of real time RT-PCR protocols to laboratories
throughout Europe allowed the detection of Schmallenberg virus
in six additional countries, including Belgium, France, Luxem-
bourg, United Kingdom, Italy, and Spain [5] and provided
evidence for the involvement of Culicoides sp. midges as possible
vectors [6].
In the absence of targeted sequencing protocols for this novel
virus, we applied a virus discovery strategy based on random
amplification of purified nucleic acids in combination with next
generation sequencing on SBV real time RT-PCR positive tissue
samples to confirm the presence of SBV and obtain preliminary
sequence data on SBV from Belgium. We previously validated this
DNase SISPA (Sequence Independent Single Primer Amplifica-
tion, [7]) approach on other RNA viruses [8,9]. It consists of a
viral nucleic acid enrichment step (size selective filtration in
combination with a nuclease treatment to remove nucleic acids
that are not encapsidated in virions) followed by a random cDNA
synthesis and amplification step. The random amplicons are
subsequently exploited by next generation sequencing [10]. The
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e41967
combination with quantitative real time RT-PCR results from the
field tissue samples allowed a first estimate of the sensitivity of this
approach using field samples infected with an emerging disease.
Results and Discussion
To test the feasibility of virus identification using DNase SISPA-
next generation sequencing (NGS) and to get a first estimate of its
sensitivity on field samples, we selected both strong and weak
positive SBV infected field samples. For viral RNA quantification,
in vitro transcribed RNA was used as a standard curve in the
previously described L gene real time RT-PCR. The curve showed
a linear range at least from 2.75 to 7.75 log10 RNA copies per mL,
and a sensitivity of less than 2.75 log10 RNA copies per mL
(Figure 1).
Two field samples of aborted lambs with Cp values of 20.59 and
20.65 corresponding to 7.66 and 7.64 log10 RNA copies per mL
(Table 1) allowed unambiguous identification of Schmallenberg
virus. One sample (BE/12-2478) yielded 2 S segment sequences
(covering about 13% of the S segment), 81 M segment sequences
(covering about 56% of the M segment) and 109 L segment
sequences (covering about 81% of the L segment) (Table 1,
Figure 2). The other strong positive sample (BE/12-2068) resulted
in a total of 8 SBV specific sequence reads distributed over the L
and M genomic segments. This difference in sequence coverage
for two samples with a comparable SBV RNA load is most likely
due to the difference in the amount of raw sequence data (Table 1).
While the sequencing of BE/12-2478 yielded about 95000 reads,
BE/12-2068 only resulted in circa 25000 reads probably due to
DNA library quantification issues at the sequencing facility.
Moreover, more tissue sample was available for DNase SISPA
protocol from sample BE/12-2478 (Table 1), although the ratio of
viral reads to total raw reads was superior (0.01) in sample BE/12-
2068 compared to sample BE/12-2478 (0.002 ; Table 2).
Three weak positive field samples (one from an aborted calf, two
from aborted lambs) containing virus quantities equivalent to
4.27–4.63 log10 RNA copies per mL did not allow identification
using DNase SISPA-NGS (Table 1). This is consistent with an
approximate sensitivity of 104–106 virions per ml estimated in
previous studies using in vitro virus dilutions [11] or tissue biopsy
samples [12]. However, it should be noted that the exact ratio
between viral RNA quantities and intact virion quantities in field
samples (the functional unit being detected in this method) remains
to be determined. Our preliminary data indicate that RNA
extracted from an SBV isolate containing 105 TCID50/ml may
contain up to 8.46 log10 RNA copies per mL (Table 1). This
indicates that precaution should be taken in interpreting RNA
quantities in terms of DNase SISPA-NGS sensitivity, which is
determined by the amount of viral nucleic acids that remain
protected in intact virions during nuclease treatment. Moreover, a
comparison of approximate sensitivity with other viral discovery
methods is almost impossible, as the utilized sequencing effort
varies from a few 100 Sanger sequencing reads [11,13] to about 30
million Illumina GAII reads [12]; and different sample types
(targeted tissue selection, freshness of the sample) may result in
different levels of host and contaminating nucleic acids. Given the
limited approximate sensitivity of DNase SISPA-NGS, as any virus
discovery method, careful selection of properly targeted and fresh
field samples is necessary.
As expected in any metagenomic approach, a considerable part
of the sequence reads represented diverse bacterial species and
host nucleic acids (Table 2). It should be noted that the field
samples were stored for a considerable time before the pretreat-
ment and RNA extraction, during which opportunistic bacteria
probably grew in the samples. Although we use a 0.22 mM filter to
remove remaining cell fragments and bacteria, nucleic acids from
disrupted cells can pass through the filter.
Figure 1. Quantification of Schmallenberg virus L segment RNA using quantitative real time RT-PCR. The viral RNA load in field samples
was quantified with real time RT-PCR using a standard curve consisting of in vitro transcribed L segment RNA spanning the diagnostic RT-qPCR,
which was run in five replicates (blue crosses). The linear trendline and the associated standard curve equation are displayed. The samples are
indicated by red squares.
doi:10.1371/journal.pone.0041967.g001
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Other viral reads could be mainly identified as bacteriophages
belonging to the families Myoviridae, Siphoviridae and Podoviridae
(Table 2). Three reads showed partial similarity to a virus belonging
to the Phycodnaviridae and two reads showed some similarity to
viruses of theMimiviridae family. None of these viruses have relatives
known to infect animals. These sequences most likely represent
contamination of the tissue samples during storage until analysis.
Compared to the metagenomic approach used by Hoffmann
and colleagues [1] that initially identified this novel Orthobunya-
virus by shotgun sequencing of total RNA extracted from clinical
samples, our virus discovery protocol attempts an enrichment in
viral nucleic acids by selective filtration and nuclease treatment. A
direct comparison between both data sets is impossible as we
treated limited amounts of tissue samples representing a different
host species. Moreover, the sequencing effort per library was not
identical. Both studies indicate the need of high sequence
throughput and proper sample selection as critical factors for
successful virus discovery using metagenomics.
The partial SBV sequence info we obtained was compared to
the whole genome sequence that was determined from the virus
originally isolated from diseased bovines in Germany. Several
coding and noncoding mutations could be observed (Table 3). The
partial data from the two Belgian ovine field samples showed
together 16 nucleotide differences (of which 9 well-supported by
the sequence data, Table 3) corresponding to 9 amino acid
differences (of which 5 well-supported). Although this can be
expected for an RNA virus that has now shown a distribution
throughout a large part of Western Europe, this is to our
knowledge the first documentation of genetic diversity within the
Schmallenberg virus outbreak. Based upon the 8134 nucleotides in
common between our partial sequence (BE/12/2478) and the
genome of the virus isolated from diseased bovine in Germany
(accession codes HE649912-HE649914), a mutation frequency of
1.7 1023 mutations per site was observed. The time frame between
the two samples was about three months and the geographical
distance between the sampling sites roughly 325 km. Although
only based on a three month period, the observed mutation
Figure 2. Mapping of Schmallenberg virus specific reads of sample BE/12-2479 against the German isolate BH80/11-4. Positional
sequence coverage (number of sequence reads for given nucleotide position) of the M and L segments of sample BE/12-2478, based on reference
assembly to HE649912 and HE649913.
doi:10.1371/journal.pone.0041967.g002
Table 1. SBV virus quantification and confirmation by DNase SISPA-NGS in selected field samples from Belgium.
Sample (location, date) Description
SBV log10 RNA
copies/ml (Cp value)
Total no.
reads
No. SBV reads per segment
(% of RNA segment covered)
S M L
BE/12-2068 (Ghoy, 13.01.2012) Brain tissue, 180 mg, aborted lamb 7,664 (20.59) 25701 - 1 (8.59) 6 (8.69)
BE/12-2478 (Deinze, 18.01.2012) Brain tissue, 1000 mg, aborted lamb 7,642 (20.65) 94722 2 (13.68) 81(59.1) 109 (81.9)
BE/12-2649 (Reningelst, 22.01.2012) Brain tissue, 1130 mg, aborted lamb 4,331 (29.83) 50308 - - -
BE/12-1235 (Sivry, 06.01.2012) Brain tissue homogenate, 1.8 ml,
aborted calf
4,630 (29.00) 27979 - - -
BE/12-3610 (Izenberge, 28.01.2012) Brain tissue, 620 mg, aborted lamb 4,270 (30.00) 98648 - - -
Isolate BE/12-2068 (Ghoy, 13.01.2012) Tissue culture supernatant. 5 log10
TCID50/ml
8,418 (18.50) nd nd nd nd
doi:10.1371/journal.pone.0041967.t001
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frequency is within the documented range of Bunyavirus
variability (1022 to 1024 mutations/site/year documented for
Hantavirus ; [14]) and within the documented range of RNA virus
variability (1023 to 1024 mutations/site/year ; [15,16]). It should
be noted that, while the samples in Germany were taken from
acutely infected bovines, the ovine samples from Belgium present
aborted lambs, making an estimation of the infection time of the
maternal animal impossible. Future targeted molecular epidemi-
ological studies including samples from the complete geographic
range of the virus may shed light on the origin and time of
introduction of this novel virus in Europe.
Our data show that DNase SISPA-NGS viral discovery technology
can be used on limited amounts of field tissue samples to identify
emerging diseases. However, the sensitivity of the method seems to
limit its applicability to samples containing about 104 to 106 virions
per ml. Consequently, when applying this methodology to a cluster of
cases of an undiagnosed disease, it is important to select properly
targeted and fresh samples as well as to test multiple diseased animals
to allow correct identification of an associated virus.
Materials and Methods
Samples
Diagnostic field samples from suspected cases of SBV related
congenital malformations in lambs and calves were selected based
on their geographical location (Table 1) and on the Cp values of
the RT-qPCR detecting the L-segment of the virus that was used
for diagnosis [1]. This study was conducted under the authoriza-
tion and supervision of the Bioethics Committee at the Veterinary
and Agrochemical Research Center (VAR), following national and
European regulations.
Viral RNA quantification
Briefly, approximately 0.5 cm3 of brain tissue was added to 1 ml
PBS and homogenized (2 min, 25 Hz) in a TissueLyser (Qiagen,
Venlo, The Netherlands). The RNA was extracted using the
RNeasy minikit (Qiagen) following manufacturer instructions and
eluted in 50 ml. 2 ml of this RNA mixture was further analyzed by
a one-step PCR using the LightCycler 480 RNA Master
Hydrolysis Probes kit (Roche Diagnostics, Vilvoorde, Belgium)
on a LightCycler 480 Real-time PCR system following manufac-
turer instructions. Primers and probe sequences for the SBV L
segment detection were kindly provided by Dr. B. Hoffmann (FLI,
Germany, available on request) and used at a final concentration
of 1 and 0.1875 mM respectively. Two highly positive brain tissue
samples (Cp,21) from aborted lambs were selected for confirma-
tion by DNase SISPA-NGS. In addition, two weak positive brain
tissue samples from lambs and one weak positive sample form a
calf were selected (Cp.28). The viral RNA load in RNA directly
extracted from these samples was quantified in the above
described real time RT-PCR using a standard curve consisting
of in vitro transcribed L segment RNA spanning the diagnostic
RT-qPCR, which was run in five replicates. The in vitro
transcribed RNA was independently quantified using three
different approaches: NanoDrop Spectrophotometer (Nanodrop
Technologies, Wilmington DE, USA), QubitH RNA assay kit on
QubitH fluorometer (Invitrogen-Life Technologies, Gent, Bel-
gium), and RNA 6000 Pico chip on the Agilent 2100 Bioanalyser
(Agilent Technologies, Diegem, Belgium).
DNase SISPA and 454 sequencing
The maximum available quantity of the limited tissue samples
(,1,5 g; Table 1) was homogenized in about 1500 mL PBS per g of
tissue using gentle homogenization in a TissueLyser (Qiagen).
Sample pretreatment and SISPA was largely performed as
previously described [8,9]. Briefly, after a centrifugation and
filtration step using 0.22 mM filters, the eluate was subjected to
DNase I treatment (100 U/200 ml sample). The resulting virion-
enriched samples were subjected to a viral RNA extraction using the
QIAamp Viral RNA Mini Kit (Qiagen). Forty units of Protector
RNase inhibitor (Roche) were added to the eluted RNA, and RNA
quality was checked using a Bioanalyzer 2100 (Agilent Technolo-
gies). The random first- and second strand cDNA synthesis was
performed with the primer FR26RV-N (59GCC GGA GCT CTG
CAG ATA TCN NNN NN 39) and primer FR20RV (59-GCC
GGA GCT CTG CAG ATA TC-39) was used in subsequent PCR
to amplify the resulting cDNA. After visualisation of the random
amplified DNA fragments on a 1% agarose gel, the fragments
between 200 and 1000 bp were excised, purified and quantified
using a Nanodrop spectrophotometer (Nanodrop Technologies).
Five micrograms of each size selected (200–1000 bp) and purified
random amplified sample were sequenced on a GS FLX+ (Roche,
Mannheim, Germany) by the Genomics Core of the University
Hospital (University of Leuven, Belgium) using multiplex identifier
(MID) identification during library preparation and their standard
procedures using GS FLX Titanium series reagents (Roche,
Mannheim, Germany). The DNA fragmentation step by nebuliza-
tion was skipped and the intention was to obtain 30000–40000
reads per library.
Table 2. Output of the metagenomic analysis on raw sequence data from the sequencing libraries from SBV-positive samples.
Sample Total no. reads
Reads withprimer tag
identification No. reads classified into superkingdom
No. unclassified
reads
Eukaryota Archaea Bacteria Viruses
BE/12-2068 25701 23370 2270 5 15543 284 (Phycodnaviridae,
Myoviridae, Siphoviridae,
Podoviridae, Bunyaviridae,
Mimiviridae)
3977
BE/12-2478 94722 86178 36690 11 36106 167 (Myoviridae, Siphoviridae,
Podoviridae, Bunyaviridae)
5543
BE/12-2649 50308 46181 6730 - 36044 8 (Siphoviridae, Podoviridae,
Mimiviridae)
2468
BE/12-1235 27979 26214 13216 5 1789 1 (Siphoviridae) 9812
BE/12-3610 98648 91458 12403 13 69057 15 (Myoviridae, Podoviridae,) 5053
doi:10.1371/journal.pone.0041967.t002
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Metagenomic analysis
As an additional control to exclude reads originating from
potential DNA contamination during the library preparation steps,
only reads containing the SISPA primer sequence were included in
the assembly. Subsequently, the SISPA primer sequences plus
additional six bases were trimmed off the reads. By using a
combination of BLAST [17] and sequence mapping with the 454
reference mapper application (version 2.6; Roche), contigs (i.e. sets
of overlapping sequence reads) and reads were classified into
different taxa.
Reference assembly
To map the obtained raw sequence data to the genome of
Schmallenberg virus, the complete coding sequence of SBV
isolate BH80/11-4 (accession codes HE649912–HE649914) was
used as reference genome in the reference assemblies of our
different field samples using SeqMan NGenH version 3
(DNASTAR, Madison, WI, USA). The reads were first trimmed
to remove primer sequences (including the primer-encoded
random N positions) as well as low quality ends. Standard
assembling and filtering parameters were used, except for a
reduced minimum match percentage. The partial sequence
information was made accessible through GenBank accession
numbers JQ861686–JQ861692, except for fragments that were
less than 200 bp in length due to the minimum fragment length
requirements dictated by GenBank.
Variability analysis
The obtained partial sequence information of SBV was compared
to the sequence of isolate BH80/11-4 (accession codes HE649912–
HE649914). Single nucleotide polymorphisms (SNP’s) were identified
using SeqMan Pro version 9 (DNASTAR, Madison, WI, USA) and
are listed in Table 3. Only sequence differences where we had at least
2 sequence reads were included. Observed sequence variants at a
position with more than 2 reads and/or with reads in both cDNA and
complementary sense and/or with reads having different start
positions were assigned a high support (Table 3).
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Table 3. Differences observed in Belgian SBV sequences in comparison with the German genome sequence of isolate BH80/11-4.
Strain, genome segment Covered regions* Number of reads
Differences observed in Belgian sequences compared to the genome of the
German isolate BH80/11-4
Nucleic acid Amino acid Depth Support6
BE/12-2068, M segment 1095–1456 1
BE/12-2068, L segment 1271–1426 2
3313–3744 4 G 3490 C E 1159 Q 4 Low
G 3637 A A 1208 T 4 Low
BE/12-2478, S segment 428–467 1
669–733 1
BE/12-2478, M segment 823–1354 12 G 836 A S 275 S 3 Low
A 983 G T 324 T 5 High
C 998 T F 329 F 4 High
A 1041 G K 344 E 4 High
T 1201 C F 397 S 8 High
1920–2211 4 G 1930 A R 640 Q 4 Low
A 1969 T Q 653 L 4 Low
2248–2390 1
2412–3935 64 A 3558 G N 1183 D 29 High
BE/12-2478, L segment 383–1844 44 G 1017 A E 334 E 9 High
1873–2682 6
2966–3744 19 C 3097 T H 1028 Y 2 High
3770–4209 4 C 3937 T H 1308 Y 3 High
4502–4754 1
4835–5888 21 T 5736 A P 1907 P 6 High
5950–6690 13 C 6045 T P 2010 P 2 Low
T 6156 C F 2047 F 5 Low
*the indicated position is relative to the position of the used reference sequence: Schmallenberg virus, isolate BH80/11-4 (Genbank: HE649912, HE649913, HE649914).
uassessment based on low/high depth, single/double orientation of the reads, equal/different starting and end position of the reads, and quality of reads.
doi:10.1371/journal.pone.0041967.t003
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